scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1471-4159.1988.TB10573.X |
P8608 | Fatcat ID | release_ghd4iqnxlfcw7ebfytwo5lephq |
P698 | PubMed publication ID | 3258014 |
P50 | author | Margaret N Warner | Q57794700 |
P2093 | author name string | J A Gustafsson | |
C Köhler | |||
T Hansson | |||
P2860 | cites work | The relative neurotoxicities of n-hexane, methyl n-butyl ketone, 2,5- hexanediol, and 2,5-hexanedione following oral or intraperitoneal administration in hens | Q23918517 |
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures | Q26778382 | ||
Toxicity and metabolism of methyl n-butyl ketone | Q39977049 | ||
Immunohistochemical localization of cytochrome P-450 in rat brain | Q44016417 | ||
Subcellular distribution of cytochrome P-450 in the brain | Q48333411 | ||
Evidence that estradiol-2/4-hydroxylase activities in rat hypothalamus and hippocampus differ qualitatively and involve multiple forms of P-450: ontogenetic and inhibition studies | Q48428814 | ||
Regulation of heme and drug metabolism activities in the brain by manganese | Q48495998 | ||
7-Ethoxycoumarin O-de-ethylase activity in rat brain microsomes | Q48710041 | ||
Mestranol-induced hypertension: Characterization of cytochrome P-450 dependent catechol estrogen formation in brain microsomes | Q48847751 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 9 | |
P304 | page(s) | 1057-1065 | |
P577 | publication date | 1988-04-01 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Regional distribution of cytochrome P-450 in the rat brain: spectral quantitation and contribution of P-450b,e, and P-450c,d | |
P478 | volume | 50 |
Q41838970 | Acute Effects of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine in a Model of Rat Designated a Poor Metabolizer of Debrisoquine |
Q48167280 | Alteration of free radical metabolism in the brain of mice infected with scrapie agent |
Q42741285 | Aryl hydrocarbon receptor-dependent induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in cerebellar granule cells from mouse |
Q40463191 | Biochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds on the central nervous system |
Q48141766 | Biotransformation of carbon tetrachloride in cultured neurons and astrocytes |
Q41193546 | Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450. |
Q48707532 | Brain microsomal metabolism of phencyclidine in male and female rats |
Q46373604 | Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol |
Q42103484 | Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain |
Q34583665 | Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase |
Q31937342 | Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase |
Q43580847 | Cyclophosphamide attenuates the degenerative changes induced by CSF from patients with amyotrophic lateral sclerosis in the neonatal rat spinal cord |
Q24643917 | Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone |
Q73199578 | Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes |
Q41676799 | Cytochrome P450-dependent biotransformation of drugs and other xenobiotic substrates in neural tissue |
Q28397217 | Cytochrome P450-mediated drug metabolism in the brain |
Q37550663 | Cytochrome p450 mRNA expression in the rodent brain: species-, sex-, and region-dependent differences |
Q48097429 | Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells |
Q47726890 | Distribution and induction of cytochrome P450 1A1 in the rainbow trout brain |
Q37238136 | Drug disposition in the mammalian eye and brain: a comparison of mechanisms |
Q35030396 | Drug-metabolizing cytochrome P450s in the brain. |
Q37558505 | Effect of ethanol on cytochrome P450 in the rat brain |
Q42167282 | Effect of lindane on hepatic and brain cytochrome P450s and influence of P450 modulation in lindane induced neurotoxicity |
Q38921093 | Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs. |
Q48624155 | Ethanol metabolism in the brain. |
Q48311726 | Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain |
Q48318586 | Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction |
Q41068140 | Expression and induction of cytochrome P-450 1A1 and P-450 2D subfamily in the rat glioma C6 cell line |
Q49017901 | Expression and localization of the CYP2B subfamily predominantly in neurones of rat brain |
Q41047773 | Expression, induction and regulation of the cytochrome P450 monooxygenase system in the rat glioma C6 cell line |
Q77638954 | High-performance liquid chromatographic methods for the analysis of haloperidol and chlorpromazine metabolism in vitro by purified cytochrome P450 isoforms |
Q33526381 | In vivo investigation of brain and systemic ketobemidone metabolism |
Q28363020 | In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats |
Q43764263 | Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain |
Q44730555 | Involvement of specific placental antigen X-P2 in rat olfaction: an immunohistochemical study in the olfactory bulb |
Q41830882 | Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system |
Q33668212 | Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs |
Q44824714 | Modeling secondary messenger pathways in neurovascular coupling |
Q41099692 | Possible role of cytochrome P450 in inactivation of testosterone in immortalized hippocampal neurons |
Q35859052 | Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds |
Q39063508 | Quantification of [(11)C]yohimbine binding to α2 adrenoceptors in rat brain in vivo |
Q72103421 | Regiospecific expression of cytochrome P‐450s and microsomal epoxide hydrolase in human brain tissue |
Q48459634 | Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine |
Q42528986 | Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera |
Q34979763 | Steroid and sterol 7-hydroxylation: ancient pathways |
Q48619015 | Suppression of 5α-androstane-3β, 17β-diol hydroxylase activity in rat pituitary by cobalt protoporphyrin: Implications for testosterone homeostasis |
Q48136337 | Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms |
Q42556052 | The effect of protoporphyrinogen oxidase inhibitors on microsomal and mitochondrial cytochromes |
Q42069216 | The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. |
Q35114132 | Toxicological interactions involving psychiatric drugs and alcohol: an update |
Q40923022 | Xenobiotic metabolism in brain |
Search more.